Innovative Industrial Properties, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Innovative Industrial Properties, Inc. ("IIPR" or "the Company") (NYSE:IIPR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated […]

Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc. (SAVA) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cassava-sciences-inc-lawsuit-submission-form?prid=124359&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Warner Bros. Discovery, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Warner Bros. Discovery, Inc. ("WBD" or "the Company") (NASDAQ:WBD) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Sun Communities, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sun Communities, Inc. ("SUI" or "the Company") (NYSE:SUI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Regeneron Pharmaceuticals, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

Newsweek and BrandSpark Most Trusted Awards Announce 12th Annual Most Trusted Brands in the U.S. for 2025 as 100% voted by American Shoppers

New Rankings Offering Consumers a Data-Driven Guide to the Most Trusted Brands AcrossConsumer Products, Services, and Retail Newsweek and BrandSpark International are proud to announce the winners of the 2025 BrandSpark Most Trusted Awards, celebrating the brands that have earned the trust of U.S. shoppers. This year's awards are based on insights from 29,420 U.S.

InventHelp Inventor Develops New Laser Tool with Anchoring System (DAL-566)

“I'm a plumbing manager and needed a better way to find the exact center of pipe, as well as to determine the length of pipes,” said an inventor, fromRoyse City, Texas, “so I invented the OFFSET MASTER. My design would streamline the measurement process.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The patent-pending invention provides an improved laser tool with an

Isocyanates Market Set to Reach USD 22.7 Billion by 2031, Fueled by Growing Demand in Automotive, Construction, and Furniture Industries – Market Research Intellect

The growth of the Isocyanates market is primarily driven by the increasing demand for polyurethane products, which are widely used in automotive, construction, and furniture industries. The rising need for durable coatings, adhesives, foams, and sealants in these sectors is boosting market growth. Additionally, the growing focus on energy-efficient materials and sustainability is driving the

Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR | MarketsandMarkets™

The globalOligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029. Rising outsourcing of development and manufacturing to CDMOs and growing focus on precision/personalized medicine are some of the factors driving the market's growth.

Smartpress Drives Success in Employee Satisfaction & Engagement

Digital printer boasts scores out-performing other American manufacturers Commercial printerSmartpress and their parent company, The Bernard Group, are revealing impressive employee-focused metrics that prove the manufacturer sets a high bar for engagement and participation. Based on employee feedback from their annual Gallup survey and other key metrics, their notable numbers highlight why the sustainable printer

Scroll to Top